−1.00 CHF
−4.34 M CHF
6.90 M CHF
606.57 K
About CURATIS N
Sector
Industry
CEO
Roland Rutschmann
Website
Headquarters
Liestal
ISIN
CH1330780979
FIGI
BBG000BGX6H3
Curatis Holding AG operates as a pharmaceutical company. It is engaged in the acquisition, development and commercialization of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. The company was founded by Gunter Graubach and is headquartered in Liestal, Switzerland.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of CURN is 11.30 CHF — it has decreased by −0.44% in the past 24 hours. Watch CURATIS N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange CURATIS N stocks are traded under the ticker CURN.
CURN stock has fallen by −2.59% compared to the previous week, the month change is a 1.80% rise, over the last year CURATIS N has showed a −6.15% decrease.
CURN reached its all-time high on Nov 15, 2024 with the price of 18.20 CHF, and its all-time low was 5.00 CHF and was reached on Aug 22, 2024. View more price dynamics on CURN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CURN stock is 8.10% volatile and has beta coefficient of −2.96. Track CURATIS N stock price on the chart and check out the list of the most volatile stocks — is CURATIS N there?
Today CURATIS N has the market capitalization of 56.60 M, it has decreased by −6.67% over the last week.
Yes, you can track CURATIS N financials in yearly and quarterly reports right on TradingView.
CURN net income for the last half-year is −476.00 K CHF, while the previous report showed −3.87 M CHF of net income which accounts for 87.70% change. Track more CURATIS N financial stats to get the full picture.
No, CURN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 31, 2025, the company has 7 employees. See our rating of the largest employees — is CURATIS N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CURATIS N EBITDA is −3.27 M CHF, and current EBITDA margin is −45.30%. See more stats in CURATIS N financial statements.
Like other stocks, CURN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CURATIS N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CURATIS N technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CURATIS N stock shows the strong buy signal. See more of CURATIS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.